Literature DB >> 819458

Herpes gestationis. Immunopathology and characterization of the HG factor.

S I Katz, K C Hertz, H Yaoita.   

Abstract

Five patients with herpes gestationis, a blistering disease of pregnancy, were studied immunologically. All had in vivo deposition of C3 in a linear band along the basement membrane zone of lesional and normal-appearing skin, the location of early blister formation. Immunoglobulin deposition was more variable, though four patients had evidence of in vivo bound IgG at the same site. A circulating, complement binding herpes gestationis factor was demonstrated in the sera of four of the patients, its concentration unrelated to the activity of clinical disease. Characterization of this factor by sucrose gradient ultracentrifugation, specific absorption studies, and papain digestion indicates that it is an IgG. Evidence exists for involvement of both the classical and alternate complement pathways in vivo, though in vitro studies implicate the classical pathway as the primary route of complement activation. Three offspring were studied, none with clinical involvement; one showed in vivo deposition of C3 at the basement membrane zone of normal skin and a second showed the herpes gestationis factor in cord blood.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819458      PMCID: PMC436802          DOI: 10.1172/JCI108413

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  Herpes gestationis. New immunologic findings.

Authors:  L L Bushkell; R E Jordon; R W Goltz
Journal:  Arch Dermatol       Date:  1974-07

2.  Immunological studies of the human placenta. Characterization of immunoglobulins on trophoblastic basement membranes.

Authors:  W P Faulk; M Jeannet; W D Creighton; A Carbonara
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

3.  Complement immunofluorescent staining in bullous pemphigoid.

Authors:  R E Jordon; W M Sams; E H Beutner
Journal:  J Lab Clin Med       Date:  1969-10

4.  The use of human skin for the detection of anti-epithelial autoantibodies. A diagnostic and prognostic test.

Authors:  S I Katz; K M Halprin; T M Inderbitzin
Journal:  J Invest Dermatol       Date:  1969-12       Impact factor: 8.551

5.  Immunofluorescence studies in herpes gestationis.

Authors:  M Kocsis; T L Eeg; G Husby; G Rajka
Journal:  Acta Derm Venereol       Date:  1975       Impact factor: 4.437

6.  Complement activation in bullous skin diseases.

Authors:  R E Jordon
Journal:  J Invest Dermatol       Date:  1975-07       Impact factor: 8.551

7.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

8.  In vivo studies in C4-deficient guinea pigs.

Authors:  L Ellman; I Green; F Judge; M M Frank
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

9.  Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.

Authors:  T T Provost; T B Tomasi
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Variability of laminin immunoreactivity in human autopsy brain.

Authors:  S Mori; N H Sternberger; M M Herman; L A Sternberger
Journal:  Histochemistry       Date:  1992

Review 3.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.

Authors:  Cassian Sitaru; Arno Kromminga; Takashi Hashimoto; Eva B Bröcker; Detlef Zillikens
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

6.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Authors:  Z Liu; L A Diaz; J L Troy; A F Taylor; D J Emery; J A Fairley; G J Giudice
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor.

Authors:  J A Carruthers; A R Ewins
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

8.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

9.  Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice.

Authors:  Z Lazarova; C Yee; T Darling; R A Briggaman; K B Yancey
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 10.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.